> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lundbeck Wins OK for Carbamazepine I.V. Formulation
- URL: https://www.fdaweb.com/lundbeck-wins-ok-for-carbamazepine-i-v-formulation/
- Published: 2016-10-10T12:00:00.000Z
- Updated: 2026-09-14T21:38:23.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5137035

FDA has approved Lundbeck’s Carnexiv (carbamazepine) injection as a short-term replacement therapy for an oral carbamazepine formulations in adults with certain seizure types when oral administration is temporarily not feasible. Carnexiv received an orphan drug designation for this indication and will be the first available intravenous formulation of the antiepileptic drug. The company says the approval was based on data from a clinical trial conducted by the University of Minnesota College of Pharmacy.